Abstract:Background and aims Genomic and transcriptomic findings greatly broaden the biological knowledge regarding substance use. However, systematic convergence and comparison evidence of genome-wide findings is lacking for substance use. Here, we combined all the genome-wide findings from both substance use behavior and disorder (SUBD) and identified common and distinguishing genetic factors for different SUBDs. Methods Systemic literature search for genome-wide association (GWAS) and RNA-seq studies of alcohol/nicotine/drug use behavior (partially meets or not reported diagnostic criteria) and alcohol use behavior and disorder (AUBD), nicotine use behavior and disorder (NUBD) and drug use behavior and disorder (DUBD) was performed using PubMed and the GWAS catalog. Drug use was focused upon cannabis, opioid, cocaine and methamphetamine use. GWAS studies required case-control or case/cohort samples. RNA-seq studies were based on brain tissues. The genes which contained significant single nucleotide polymorphism (P <= 1 x 10(-6)) in GWAS and reported as significant in RNA-seq studies were extracted. Pathway enrichment was performed by using Metascape. Gene interaction networks were identified by using the Protein Interaction Network Analysis database. Results Total SUBD-related 2910 genes were extracted from 75 GWAS studies (2 773 889 participants) and 17 RNA-seq studies. By overlapping the genes and pathways of AUBD, NUBD and DUBD, four shared genes (CACNB2, GRIN2B, PLXDC2 and PKNOX2), four shared pathways [two Gene Ontology (GO) terms of 'modulation of chemical synaptic transmission', 'regulation of trans-synaptic signaling', two Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of 'dopaminergic synapse', 'cocaine addiction'] were identified (significantly higher than random, P < 1 x 10(-5)). The top shared KEGG pathways (Benjamini-Hochberg-corrected P-value < 0.05) in the pairwise comparison of AUBD versus DUBD, NUBD versus DUBD, AUBD versus NUBD were 'Epstein-Barr virus infection', 'protein processing in endoplasmic reticulum' and 'neuroactive ligand-receptor interaction', respectively. We also identified substance-specific genetic factors: i.e. ADH1B and ALDH2 were unique for AUBD, while CHRNA3 and CHRNA4 were unique for NUBD. Conclusions This systematic review identifies the shared and unique genes and pathways for alcohol, nicotine and drug use behaviors and disorders at the genome-wide level and highlights critical biological processes for the common and distinguishing vulnerability of substance use behaviors and disorders.

A Genome-Wide Multiphenotypic Association Analysis Identified Candidate Genes and Gene Ontology Shared by Four Common Risky Behaviors.

Multivariate Genomic Analysis of 1.5 Million People Identifies Genes Related to Addiction, Antisocial Behavior, and Health

A Genome-Wide Multiphenotypic Association Analysis Identified Common Candidate Genes for Subjective Well-Being, Depressive Symptoms and Neuroticism

Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction

Investigating the shared genetic architecture between attention-deficit/hyperactivity disorder and risk taking behavior: A large-scale genomewide cross-trait analysis

Integrative Analysis of Genome-Wide Association Studies Identifies Novel Loci Associated with Neuropsychiatric Disorders

Common and Distinguishing Genetic Factors for Substance Use Behavior and Disorder: an Integrated Analysis of Genomic and Transcriptomic Studies from Both Human and Animal Studies

Prioritization of Schizophrenia Risk Genes from GWAS Results by Integrating Multi-Omics Data.

S003329172000272Xjra 968..978

Characterising the shared genetic determinants of bipolar disorder, schizophrenia and risk-taking

Post-GWAS Analysis of Six Substance Use Traits Improves the Identification and Functional Interpretation of Genetic Risk Loci.

Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease

Identification of Novel Risk Loci with Shared Effects on Alcoholism, Heroin, and Methamphetamine Dependence

A New Genomewide Association Meta-Analysis of Alcohol Dependence.

Multivariate Analysis of Genome-Wide Data to Identify Potential Pleiotropic Genes for Type 2 Diabetes, Obesity and Coronary Artery Disease Using MetaCCA

Genetic Study Identifies CBLN4 As a Novel Susceptibility Gene for Accident Proneness

Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.

Genome-wide Association Study Identifies Common Genetic Risk Factors for Alcohol, Heroin and Methamphetamine Dependence

Gene-based and Pathway-Based Genome-Wide Association Study of Alcohol Dependence.

Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors